Search

Current filters: HIV drugs, HIV, Treatment, Drug treatment strategies

Switching to Dovato (dolutegravir + 3TC) from a TAF-based regimen

From TreatmentUpdate 233
2019, CATIE
Research summary - Webpage

Dovato (dolutegravir + 3TC) in initial HIV treatment

From TreatmentUpdate 233
2019, CATIE
Research summary - Webpage

Update of recommendations on first- and second-line antiretroviral regimens

2019, World Health Organization (WHO)
Guideline or manual - PDF
More info

Can high-dose dolutegravir be a rescue therapy?

From TreatmentUpdate 230
2019, CATIE
Research summary - Webpage

De-simplifying single-tablet regimens for HIV treatment

2019, CATIE
Research summary - Webpage

Italian study explores dual drug regimens as maintenance treatment

From TreatmentUpdate 229
2018, CATIE
Research summary - Webpage

Dual maintenance therapy with dolutegravir + rilpivirine

From TreatmentUpdate 229
2018, CATIE
Research summary - Webpage

Dolutegravir + 3TC for the initial treatment of HIV

From TreatmentUpdate 229
2018, CATIE
Research summary - Webpage

Switching from Triumeq to Biktarvy

From TreatmentUpdate 228
2018, CATIE
Research summary - Webpage

Switching to Biktarvy from a protease inhibitor–based regimen

From TreatmentUpdate 228
2018, CATIE
Research summary - Webpage